BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25155986)

  • 1. Structure-guided design of thiazolidine derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Devi PB; Samala G; Sridevi JP; Saxena S; Alvala M; Salina EG; Sriram D; Yogeeswari P
    ChemMedChem; 2014 Nov; 9(11):2538-47. PubMed ID: 25155986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Samala G; Nallangi R; Devi PB; Saxena S; Yadav R; Sridevi JP; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2014 Aug; 22(15):4223-32. PubMed ID: 24953948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of Novel Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors: Virtual Screening, Synthesis and In Vitro Biological Activities.
    Devi PB; Jogula S; Reddy AP; Saxena S; Sridevi JP; Sriram D; Yogeeswari P
    Mol Inform; 2015 Feb; 34(2-3):147-59. PubMed ID: 27490037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads.
    Samala G; Devi PB; Nallangi R; Sridevi JP; Saxena S; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2014 Mar; 22(6):1938-47. PubMed ID: 24565972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase.
    Baig IA; Moon JY; Lee SC; Ryoo SW; Yoon MY
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1338-50. PubMed ID: 25988243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-guided design of novel thiazolidine inhibitors of O-acetyl serine sulfhydrylase from Mycobacterium tuberculosis.
    Poyraz O; Jeankumar VU; Saxena S; Schnell R; Haraldsson M; Yogeeswari P; Sriram D; Schneider G
    J Med Chem; 2013 Aug; 56(16):6457-66. PubMed ID: 23879381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of 3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as novel Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Samala G; Devi PB; Nallangi R; Yogeeswari P; Sriram D
    Eur J Med Chem; 2013 Nov; 69():356-64. PubMed ID: 24077526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Samala G; Devi PB; Saxena S; Meda N; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2016 Mar; 24(6):1298-307. PubMed ID: 26867485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A discovery of novel Mycobacterium tuberculosis pantothenate synthetase inhibitors based on the molecular mechanism of actinomycin D inhibition.
    Yang Y; Gao P; Liu Y; Ji X; Gan M; Guan Y; Hao X; Li Z; Xiao C
    Bioorg Med Chem Lett; 2011 Jul; 21(13):3943-6. PubMed ID: 21641210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of pyrazole-based inhibitors to Mycobacterium tuberculosis pantothenate synthetase: docking and MM-GB(PB)SA analysis.
    Ntie-Kang F; Kannan S; Wichapong K; Owono Owono LC; Sippl W; Megnassan E
    Mol Biosyst; 2014 Feb; 10(2):223-39. PubMed ID: 24240974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based virtual screening as a tool for the identification of novel inhibitors against Mycobacterium tuberculosis 3-dehydroquinate dehydratase.
    Petersen GO; Saxena S; Renuka J; Soni V; Yogeeswari P; Santos DS; Bizarro CV; Sriram D
    J Mol Graph Model; 2015 Jul; 60():124-31. PubMed ID: 26043661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel inhibitor of Mycobacterium tuberculosis pantothenate synthetase.
    White EL; Southworth K; Ross L; Cooley S; Gill RB; Sosa MI; Manouvakhova A; Rasmussen L; Goulding C; Eisenberg D; Fletcher TM
    J Biomol Screen; 2007 Feb; 12(1):100-5. PubMed ID: 17175524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-tert-butyl-N-pyrazol-4-yl-4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxamide derivatives as novel potent inhibitors of Mycobacterium tuberculosis pantothenate synthetase: initiating a quest for new antitubercular drugs.
    Velaparthi S; Brunsteiner M; Uddin R; Wan B; Franzblau SG; Petukhov PA
    J Med Chem; 2008 Apr; 51(7):1999-2002. PubMed ID: 18335974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrids of thienopyrimidinones and thiouracils as anti-tubercular agents: SAR and docking studies.
    Pisal MM; Nawale LU; Patil MD; Bhansali SG; Gajbhiye JM; Sarkar D; Chavan SP; Borate HB
    Eur J Med Chem; 2017 Feb; 127():459-469. PubMed ID: 28103537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, biological evaluation of substituted benzofurans as DNA gyraseB inhibitors of Mycobacterium tuberculosis.
    Renuka J; Reddy KI; Srihari K; Jeankumar VU; Shravan M; Sridevi JP; Yogeeswari P; Babu KS; Sriram D
    Bioorg Med Chem; 2014 Sep; 22(17):4924-34. PubMed ID: 25129171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of Antitubercular Compound Library Identifies Inhibitors of Mur Enzymes in
    Eniyan K; Rani J; Ramachandran S; Bhat R; Khan IA; Bajpai U
    SLAS Discov; 2020 Jan; 25(1):70-78. PubMed ID: 31597510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
    Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
    Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel inhibitors against Mycobacterium tuberculosis L-alanine dehydrogenase (MTB-AlaDH) through structure-based virtual screening.
    Saxena S; Devi PB; Soni V; Yogeeswari P; Sriram D
    J Mol Graph Model; 2014 Feb; 47():37-43. PubMed ID: 24316937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of Inhibitors of Mycobacterium tuberculosis Pantothenate Synthetase Based on Group Efficiency Analysis.
    Hung AW; Silvestre HL; Wen S; George GP; Boland J; Blundell TL; Ciulli A; Abell C
    ChemMedChem; 2016 Jan; 11(1):38-42. PubMed ID: 26486566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MM2QM tool for combining docking, molecular dynamics, molecular mechanics, and quantum mechanics.
    Nowosielski M; Hoffmann M; Kuron A; Korycka-Machala M; Dziadek J
    J Comput Chem; 2013 Apr; 34(9):750-6. PubMed ID: 23233437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.